Cardiovascular Diseases


Bedtime BP-lowering Medications Work Better

A Spanish multicenter, controlled, prospective endpoint trial suggested that routinely taking blood pressure (BP)-lowering medications at bedtime, as opposed to upon waking, results in improved ambulatory BP (ABP) control and decreased occurrence of major cardiovascular disease (CVD) events. A total of 19 084 hypertensive patients (60.5 ± 13.7 years of age,  8470 women) […]


Hypothermia Improved Neurologic Outcome for Cardiac Arrest with Nonshockable Rhythm

A French open-label, randomized, controlled trial showed that among patients with coma who had been resuscitated from cardiac arrest with nonshockable rhythm (asystole or pulseless electrical activity), the use of moderate therapeutic hypothermia at 33°C led to a higher percentage of patients who survived with a favorable neurologic outcome at […]


Optimism Linked to Lower CVD and Mortality Risk

A meta-analysis and systematic review suggested that optimism is associated with a lower risk of events of cardiovascular diseases (CVD) and all-cause mortality. The analysis included 15 studies of 229 391 participants, in which 10 studies reported data on CVD events (including CVD mortality, nonfatal myocardial infarction, stroke, and/or new-onset angina) […]


Optimized BP Thresholds According to Risks

A Korean population-based cohort study suggests that intensive blood pressure (BP) control is appropriate for reducing all-cause mortality in addition to cardiorenal risk in higher- rather than lower-risk patients. A total of 1 402 975 adults aged 40 to 79 years who had no known cardiorenal disease were included from 2002 to […]


Do MI Women Commonly Present with Atypical Symptoms?

Do MI Women Commonly Present with Atypical Symptoms? Not really, according to a prospective study in Scotland. The study included 1941 patients (39% women) with suspected acute coronary syndrome. Standardized criteria defined typical and atypical presentations based on pain nature, location, radiation, and additional symptoms. Diagnosis of myocardial infarction (MI) […]


Omega-3 Fatty Acids Recommended for Hypertriglyceridemia; Dapagliflozin Effective in HF; Plant‐Based Diets Linked to Lower CVD Risk

A science advisory from the American Heart Association recommended that prescription n-3 fatty acids (eicosapentaenoic acid [EPA]+docosahexaenoic acid [DHA] or EPA-only) at a dose of 4 g/d (>3 g/d total EPA+DHA) are an effective and safe option for reducing triglycerides as monotherapy or as an adjunct to other lipid-lowering agents […]